BACE-1 INHIBITOR; 797035-11-1; beta-Secretase Inhibitor IV; 3-N-[(2S,3R)-4-(cyclopropylamino)-3-hydroxy-1-phenylbutan-2-yl]-5-[methyl(methylsulfonyl)amino]-1-N-[(1R)-1-phenylethyl]benzene-1,3-dicarboxamide; CHEMBL378225; 5HA; N-[(1S,2R)-1-BENZYL-3-(CYCLOPROPYLAMINO)-2-HYDROXYPROPYL]-5-[METHYL(METHYLSULFONYL)AMINO]-N'-[(1R)-1-PHENYLETHYL]ISOPHTHALAMIDE; N1-((2S,3R)-4-(Cyclopropylamino)-3-hydroxy-1-phenylbutan-2-yl)-5-(N-methylmethylsulfonamido)-N3-((R)-1-phenylethyl)isophthalamide; 1,3-Benzenedicarboxamide,N1-[(1S,2R)-3-(cyclopropylamino)-2-hydroxy-1-(phenylmethyl)propyl]-5-[methyl(methylsulfonyl)amino]-N3-[(1R)-1-phenylethyl]-; Merck-3; BACE Inhibitor C3; 2b8l; Isophthalamide Derivative 24; (2)-Secretase Inhibitor IV; beta -Secretase Inhibitor IV; SCHEMBL4567212; 5-Substituted isophthalamide, 1; BDBM16034; GTPL11713; XGB03511; ZINC14960423; compound 24 [PMID: 17432843]; NCGC00386495-01; HY-10133; hydroxyethylamine (HEA) derived inhibitor 1; CS-0002466; Q27455765; L-000384950; 1-N-[(2S,3R)-4-(cyclopropylamino)-3-hydroxy-1-phenylbutan-2-yl]-5-(N-methylmethanesulfonamido)-3-N-[(1R)-1-phenylethyl]benzene-1,3-dicarboxamide; N-((1S,2R)-1-Benzyl-3-cyclopropylamino-2-hydroxy-propyl)-5-(methanesulfonyl-methyl-amino)-N'-((R)-1-phenyl-ethyl)-isophthalamide; N-[(1S,2R)-1-benzyl-3-(cyclopropylamino)-2-hydroxypropyl]-5-[methyl(methylsulfonyl)amino]-N-[(1R)-1-phenylethyl]benzene-1,3-dicarboxamide; N-[(1S,2R)-1-Benzyl-3-(cyclopropylamino)-2-hydroxypropyl]-N'-[(R)-1-phenylethyl]-5-[methyl(methylsulfonyl)amino]isophthalamide